Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation (2020)

Peer-Reviewed Study · Yang L, Youngblood H, Wu C, Zhang Q · June 1, 2020

Yang L et al., 2020-06-01: Review of methylene blue and photobiomodulation as separate mitochondrial-targeting neuroprotective strategies. It records the shared mechanism that the combination claim rests on, and treats the two as parallel rather than combined interventions.

This review will discuss two widely studied approaches for the improvement of brain mitochondrial respiration, methylene blue (MB) and photobiomodulation (PBM).

Yang L et al., 2020-06-01: Review of methylene blue and photobiomodulation as separate mitochondrial-targeting neuroprotective strategies. It records the shared mechanism that the combination claim rests on, and treats the two as parallel rather than combined interventions. Study type: narrative review. N=not applicable. Country: United States (Augusta University). Dose: not applicable. Content: discusses MB and PBM separately as mitochondrial modulators for neuroinflammation and oxidative injury; no combined human protocol is reported. COI: none recorded in record. Funder: NIH grants listed in record. Review articles are extrapolation, not primary evidence of an enhanced effect. Also filed as MTC-062 (claims C10, C5). Study type: review.